ArticleFrontiers in oncology2025

Predicting immunotherapy response in stage III-IV non-small cell lung cancer using integrated radiomics and clinical features.

Na Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.